Array ( [episodeID] => 406 [featureSeriesID] => 1 [featureSeasonID] => 15 [featureEpisodeID] => 10 [featureTitle] => Kevin Aron on Medshield's 2027 medical aid increases [featureDescription] => Medical aid costs are rising again in 2027, forcing South Africans to weigh higher contributions against the actual healthcare value they receive.\r\n\r\nKevin Aron, Principal Officer at Medshield Medical Scheme, explains the thinking behind Medshield’s 7.9% weighted average contribution increase and why balancing affordability with long-term sustainability remains difficult.\r\n\r\nAron discusses rising healthcare inflation, regulatory pressures, prescribed minimum benefits, and why many members are moving towards more affordable options. He also explains how Medshield is reducing selected co-payments, increasing benefit limits, and using excess solvency to return more value to members.\r\n\r\nThe discussion covers new oncology co-funding for expensive treatments, extending child-dependent status from age 21 to 24, and Medshield’s partnership with Sanlam as healthcare becomes increasingly connected to broader financial wellness.\r\n\r\n0:00 Intro\r\n1:09 Medshield's 2027 contribution increases\r\n4:31 Why medical aid keeps getting more expensive\r\n7:42 Reducing co-payments and improving value\r\n9:39 Funding expensive cancer treatments\r\n12:04 Extending child-dependent cover\r\n13:49 Medshield's partnership with Sanlam\r\n\r\nFollow BusinessTech:\r\nX - https://twitter.com/businesstechSA\r\nFacebook - https://web.facebook.com/BusinessTechSA\r\nInstagram - https://www.instagram.com/businesstechsa\r\nWebsite - https://businesstech.co.za/news/\r\n\r\n#MedicalAid #Healthcare #Medshield [featureEpisode] => https://player.vimeo.com/video/1235282814 [featureDuration] => 15:58 min [featureImageMobile] => img/guests/ET-001-0030-010.jpg [featurePublication] => 2026-10-13 06:55:44 [featureLogo] => img/logos/SL115.png )